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Introduction
Liver resection remains the treatment of choice for most liver tumors, and during the last two decades, advances in laparoscopic surgery have revolutionized the procedure. The main advantages of laparoscopic surgery include reduced postoperative pain, shortened hospital stay, and improved cosmesis (1) .
In 1992, Gagner et al. reported the first successful laparoscopic liver resection (LLR) for a benign liver tumor (2); this was followed in 1993 by the first successful LLR for liver metastasis performed by Wayand and Woisetschläger (3) . Since that time, numerous cases of LLR have been performed worldwide for various indications, including hepatocellular carcinoma, colorectal liver metastasis, and various benign pathologies (4) .
Laparoscopic hepatic parenchymal transection depends more on energy devices and staplers than the open approach because the standard "clamp-crush technique" is difficult and time-consuming to apply laparoscopically (5) (6) (7) (8) (9) (10) . Many devices using either advanced bipolar energy, such as LigaSure (Covidien, Minneapolis, USA), or ultrasonic energy, such as Harmonic ACE (Ethicon Endo-Surgery, Cincinnati, USA), have been developed for laparoscopy (11) , and they have been well-studied in humans and animals.
THUNDERBEAT (TB) (Olympus Medical Systems Corp, Tokyo, Japan) is the first device to use both bipolar and ultrasound energies at the same time. Therefore, it theoretically has the advantages of ultrasonic devices, which seal and cut the vessels simultaneously to allow for faster tissue division, and bipolar devices, which can seal vessels up to 7 mm in size with minimal thermal spread. To the best of our knowledge, there have been no previous studies about the safety and efficacy of the TB device in hepatic parenchymal transection. Therefore, the aim of this study was to evaluate the safety and efficacy of the TB device in LLR.
Materials and Methods

Patients
Between January 2010 and September 2016, 142 adult patients underwent LLR at Kyoto University Hospital. Of these patients, we excluded those who had undergone hand-assisted LLR, laparoscopic-assisted liver resection, or laparoscopic liver resection that had been converted to open liver resection. This left us with 80 patients. We divided the patients into two groups: the TB group (n = 16) and the Harmonic (Hr) group (n = 64). TB has been used in LLR in our institute since 2014.
To avoid selection bias, we performed propensity score matching at a 1-to-2 ratio based on seven covariates: (i) age; (ii) background liver; (iii) Child-Pugh score; (iv) tumor size; (v) tumor location; (vi) multiplicity; and (vii) the extent of liver resection. Finally, 48 patients were enrolled in the study: 16 in the TB group and 32 in the Hr group. We retrospectively reviewed the patient characteristics, intraoperative parameters, and postoperative outcomes of all cases. The study was approved by the ethics committee of Kyoto University and conducted in accordance with the Declaration of Helsinki.
Preoperative parameters
The liver function of each patient was assessed based on albumin, prothrombin time, total and direct bilirubin, liver enzymes, Child-Pugh classification, and indocyanine green retention rate at 15 min. Each patient's tumor markersspecifically, α-fetoprotein (AFP), Protein induced by vitamin K absence or antagonist-II (PIVKA-II), carbohydrate antigen 19.9, and carcinoembryonic antigen-were also evaluated. Preoperative imaging studies included abdominal CT, MRI, and, if required, fluorodeoxyglucose PET. In addition, 3-D images of the liver were derived from preoperative CT images with SYNAPS VINCENT software (Fujifilm Medical, Tokyo, Japan) (12) .
Liver segments were defined using Couinaud's classification (13) . Anterolateral segments included segments 2-6, and posterosuperior segments included segments 1, 7, and 8. Cases with multiple tumors or tumors extending to more than one segment in both the anterolateral and posterosuperior segments were classified as posterosuperior.
As a policy, LLR is the standard procedure at our institute. The contraindication for LLR was close proximity to major vascular structures, including the inferior vena cava (IVC), or to portal and hepatic veins. Non-anatomical liver resection was defined as resection of the liver tumor with an adequate resection margin, regardless of the anatomical distribution of the portal vein branches.
Surgical technique
The LLR technique used in our institution was described previously (14, 15) . Patients were usually placed in the French position (low lithotomy position), four or five trocars were inserted, and the abdomen was insufflated with CO 2 at a pressure of 10-12 mmHg. Intraoperative contrast-enhanced ultrasound with a flexible probe was used to confirm the site, size, and number of the lesions and their relations to the intrahepatic vascular structures ( Figure 1 ). Then the resection line was marked using monopolar diathermy. Intermittent vascular inflow occlusion (Pringle maneuver) was used during parenchymal transection when needed.
Parenchymal transection was performed with either TB or ultrasonically activated coagulating shears (Harmonic scalpel, Ethicon Endo-Surgery) with or without the Cavitron Ultrasonic Surgical Aspirator (Tyco Healthcare, Mansfield, USA) ( Figure 2 ). Intraparenchymal vascular and biliary structures were divided with TB, ultrasonic shears, or clips. Endoscopic staplers were used only to divide the hepatic veins extrahepatically, as in left lateral segmentectomy.
Central venous pressure was kept low during the operation to increase the hemostatic effect of pneumoperitoneum. The specimen was removed using an endoscopic retrieval bag through an umbilical port incision. Abdominal drains were not used except in cases in which there were concerns regarding hemostasis or suspected bile leak. 
Postoperative parameters
The postoperative complications were graded according to the Clavian-Dindo classification (16) . A death was considered to be operative mortality if the patient died before discharge from the hospital or within 90 days after the operation. In cases of hepatocellular carcinoma and colorectal liver metastasis, follow-up was conducted every 4 months. At follow-up, serum tumor marker levels-specifically, either AFP and PIVKAII or carbohydrate antigen 19.9 and carcinoembryonic antigen-were measured, and abdominal CT was performed.
Statistical analysis
Propensity score matching was performed with the nearest-neighbor method at a 1-to-2 ratio based on seven covariates. Before and after matching, all variables were compared using the χ 2 test or Fisher's exact test for categorical data and the Mann-Whitney U-test for continuous data. All continuous data were expressed as medians and interquartile ranges. A P-value of less than 0.05 was considered significant. Propensity score matching was performed using the MatchIt package for R software (R for Windows 3.3.2; the R Foundation for Statistical Computing, Vienna, Austria). All statistical analyses were performed using STATA 14 (Stata Corp, College Station, USA).
Results
Preoperative parameters
Patient characteristics for both groups after matching are summarized in Table 1 . There were no differences in age, gender, BMI, or laboratory investigations between the TB group and Hr group. However, two patients (6%) in the Hr group had impaired liver function and were classified as Child-Pugh B. Tumor number, site, and size were matched between the groups. Most of the tumors in the TB group and Hr group were in the anterolateral segments, and the maximum tumor size was 45 mm in both groups.
Intraoperative parameters
The intraoperative data are shown in Table 2 . In the TB group, 14 patients (88%) underwent laparoscopic nonanatomical resection, and 2 patients (12%) underwent laparoscopic left lateral segmentectomy. In the Hr group, 27 patients (84%) underwent laparoscopic nonanatomical resection, and 5 patients (16%) underwent laparoscopic left lateral segmentectomy. Although the liver resection type was matched between the groups, the Hr group had a shorter operative time (297 min vs 255 min) and mean ischemic time (35.63 min vs 21.15 min); however, the differences were not statistically significant (P = 0.32, P = 0.27, respectively). Also, the estimated blood loss was lower in the Hr group, but the difference was not statistically significant (P = 0.08). Blood transfusion was required in one patient in the TB group and in two patients in the Hr group. There was no significant difference between the groups in the number of additional energy devices and staplers used for the parenchymal transection. One patient in the TB group underwent simultaneous laparoscopic sigmoidectomy, and one patient in the Hr group underwent simultaneous laparoscopic anterior resection. Table 2 summarizes the pathological findings in the two groups. There was no significant difference between the groups with regard to tumor type and surgical margin size. An R0 resection margin was obtained in 14 patients (88%) in the TB group and in all patients in the Hr group.
Pathological data
Postoperative outcomes
There was no statistically significant difference between the groups with regard to postoperative complications based on the Clavien-Dindo classification (Table 2 ). In the Hr group, one patient had portal vein thrombosis and was treated conservatively with anticoagulant therapy; another patient had bile leakage that was managed by percutaneous drainage of the bile collection; and a third patient developed postoperative lung atelectasis that was treated by bi-level positive airway pressure. The median postoperative hospital stay was comparable between the two groups (P = 0.62). No postoperative mortality occurred in either group within 90 days.
Discussion
Parenchymal transection remains the most important step in liver resection, and it greatly affects operative time, intraoperative blood loss, blood transfusion, and postoperative morbidity and mortality (17) . Different techniques exist for parenchymal transection, but the clamp-crush technique with continuous inflow occlusion has been proven to be better than others for blood loss, transection time, and overall cost (17, 18) . In LLR, the clamp-crush technique is difficult and time-consuming, so parenchymal transection depends more on energy devices and staplers. The two most common energy devices used worldwide are bipolar vessel-sealing systems (e.g. LigaSure, EnSeal (Ethicon Endo-Surgery, Cincinnati, USA)) and ultrasonic devices (e.g. Harmonic, SonoSurg (Olympus Medical Systems Corp, Tokyo, Japan)), which have been proven to be safe and effective in hepatic parenchymal transection (19) .
TB is the first device to combine both ultrasonically generated heat energy and advanced bipolar energy; this combination enables surgeons to simultaneously seal and cut vessels up to 7 mm in size with minimal thermal spread. The instrument is designed to provide precise dissection and grasping capabilities, with bipolar energy delivered through the lateral margins of the tip and the ultrasonic energy delivered through the central part of the tip. The device has two modes: "Seal & Cut," which enables the surgeon to coagulate and seal then cut the vessels, and "Seal," which uses the bipolar energy only for coagulation and hemostasis without cutting.
Several animal studies have been performed to evaluate the efficacy of TB and to compare it with other energy devices (20) (21) (22) . Tanaka et al. compared TB with ultrasonic devices (Sonicision and Harmonic ACE) in a porcine model (21) , and they found that the cutting speed was faster, the burst pressure was higher, and the perpendicular width of the tissue seal was longer with TB. Milsom et al. compared TB with LigaSure, EnSeal, and Harmonic ACE in a porcine model. They reported that TB had a greater versatility with a faster dissection speed than the other instruments, but the bursting pressure and thermal spread of TB were similar to the other instruments (22) .
Based on these animal model studies, TB has been proven to be superior to other energy devices. In contrast, the available clinical studies in humans could not prove the superiority of TB over other energy devices, except for conventional monopolar and bipolar electrical devices (23) (24) (25) . Fagotti et al. performed a randomized controlled trial comparing TB with standard electrosurgery during laparoscopic radical hysterectomy with pelvic lymphadenectomy and found that TB was associated with a shorter operative time and less postoperative pain (23) .
Another retrospective non-inferiority study compared TB with the ultrasonic Harmonic Focus in patients receiving partial or total open thyroidectomy; this study reported that TB was not inferior to the Harmonic Focus in terms of operative time, intraoperative blood loss, and hospital stay (24) .
The most recent retrospective study compared TB with other three energy devices (ultrasonic coagulating shears, standard electrosurgery, and electrothermal bipolar vessel sealers) in patients who underwent laparoscopic colorectal resection. It showed that the four devices were equally safe and effective but that blood loss was higher in standard electrosurgery (25) .
No previous studies regarding the use of TB in LLR were found. Our series was the first to evaluate and compare TB and an ultrasonic device in LLR. We did not find any significant difference between the two devices with regard to operative time and intraoperative blood loss. This result may have occurred because of our lack of experience using TB. Postoperative complications and hospital stay were similar between the groups.
Our study had some limitations because it was a retrospective study with a small number of patients. Also, all cases in our study were non-anatomical partial resection and left lateral sectionectomy; this can be mainly attributed to the coverage provided by national health insurance in Japan, which includes only these procedures. Therefore, a large randomized clinical trial is needed to evaluate the safety and efficacy of TB in LLR.
In conclusion, this was the first clinical study on the use of TB in LLR. TB is as safe and effective for parenchymal transection in laparoscopic hepatectomy as ultrasonic devices, but it is not a superior alternative.
